[1] JEYASEELAN R, POIZAT C, BAKER RK, et al. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes[J]. J Biol Chem, 1997, 272(36):22800-22808. [2] KOJIC S, RADOJKOVIC D, FAULKNER G. Muscle ankyrin repeat proteins:their role in striated muscle function in health and disease[J]. Crit Rev Clin Lab Sci, 2011, 48(5/6):269-294. [3] 马国达, 肖兴军. 心肌锚定重复序列蛋白CARP的研究进展[J]. 生命科学, 2009, 21(3):377-382. [4] LING SSM, CHEN YT, WANG J,et al. Ankyrin repeat domain 1 protein:A functionally pleiotropic protein with cardiac biomarker potential[J]. Int J Mol Sci, 2017, 18(7):E1362. [5] 许家林. 心肌铆定重复序列蛋白(CARP)对心肌肥厚保护功能与分子机制[D]. 北京:北京协和医学院,2009. [6] HAN XJ, CHAE JK, LEE MJ, et al. Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cells[J]. J Biol Chem, 2005, 280(24):23122-23129. [7] LEE MJ, KWAK YK, YOU KR, et al. Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury[J]. Exp Mol Med, 2009, 41(4):243-252. [8] SONG Y, XU JL, LI YF, et al. Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways[J]. PLoS One, 2012, 7(12):e50436. [9] ZHANG N, YE F M, ZHU W, et al. Cardiac ankyrin repeat protein attenuates cardiomyocyte apoptosis by upregulation of Bcl-2 expression[J]. Biochim Biophys Acta, 2016, 1863(12):3040-3049. [10] 马国达,崔玉东,翁凡,等. CARP抗体制备及表达模式分析[J]. 细胞与分子免疫学杂志, 2009, 25(6):507-509,512. [11] CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. [12] RUGGERI C, GIOFFRÉ S, ACHILLI F, et al. Role of microRNAs in doxorubicin-induced cardiotoxicity:An overview of preclinical models and cancer patients[J]. Heart Fail Rev, 2018, 23(1):109-122. [13] RENU K, V G A, P B T P, et al. Molecular mechanism of doxorubicin-induced cardiomyopathy-An update[J]. Eur J Pharmacol, 2018, 818:241-253. [14] WU V. Dexrazoxane:a cardioprotectant for pediatric cancer patients receiving anthracyclines[J]. J Pediatr Oncol Nurs, 2015, 32(3):178-184. [15] MILLER M K, BANG M L, WITT C C, et al. The muscle ankyrin repeat proteins:CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules[J]. J Mol Biol, 2003, 333(5):951-964. [16] LANGE S, GEHMLICH K, LUN A S, et al. MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy[J]. Nat Commun, 2016, 7:12120. [17] ZOU Y, EVANS S, CHEN J, et al. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway[J]. Development, 1997, 124(4):793-804. [18] ROCHETTE L, GUENANCIA C, GUDJONCIK A, et al. Anthracyclines/trastuzumab:new aspects of cardiotoxicity and molecular mechanisms[J]. Trends Pharmacol Sci, 2015, 36(6):326-348. [19] SAWYER D B, PENG X Y, CHEN B, et al. Mechanisms of anthracycline cardiac injury:can we dentify strategies for cardioprotection?[J]. Prog Cardiovasc Dis, 2010, 53(2):105-113. [20] CHEN B, ZHONG L, ROUSH S F, et al. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray:implications for anthracycline cardiomyopathy[J]. PLoS One, 2012, 7(4):e35743. |